Moolec Science (MLECW) Receivables - Net (2022 - 2025)
Moolec Science (MLECW) posted Receivables - Net of $6.1 million for Q2 2025, up 215.34% sequentially from $1.9 million in Q4 2024, and down 97.09% YoY from $209.0 million in Q2 2024.
Moolec Science (MLECW) Receivables - Net (2022 - 2025) Analysis & Trends
Moolec Science has reported Receivables - Net for 4 years, with the latest figure at $6.1 million in Q2 2025.
- Quarterly Receivables - Net fell 97.09% year-over-year to $6.1 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $6.1 million (down 97.09% YoY) and the FY2025 annual result came in at $6.1 million, down 97.09% from the prior year.
- Receivables - Net advanced to $6.1 million in Q2 2025 per MLECW's latest filing, from $1.9 million in the prior quarter.
- Over five years, Receivables - Net peaked at $209.0 million in Q2 2024 and troughed at $2061.0 in Q2 2022.
- A 4-year average of $22.3 million and a median of $1.9 million in 2024 frame the typical range for Receivables - Net.
- The sharpest annual moves came in 2024 and 2025: Receivables - Net jumped 57781.18% in 2024, then tumbled 97.09% in 2025.
- Over 4 years, Receivables - Net stood at $8.1 million in 2022, then tumbled by 96.47% to $284849.0 in 2023, then jumped by 577.48% to $1.9 million in 2024, then jumped by 215.34% to $6.1 million in 2025.
- According to Business Quant data, Receivables - Net over the past three periods registered $6.1 million, $1.9 million, and $553542.0 for Q2 2025, Q4 2024, and Q3 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Moolec Science | 8,617.72 | -1.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 6.09 Mn |
| Jun 30, 2025 | 6.09 Mn |
| Dec 31, 2024 | 1.93 Mn |
| Dec 31, 2024 | 1.93 Mn |
| Sep 30, 2024 | 553,542.00 |
| Sep 30, 2024 | 553,542.00 |
| Jun 30, 2024 | 209.01 Mn |
| Jun 30, 2024 | 209.01 Mn |
| Mar 31, 2024 | 548,336.00 |
| Mar 31, 2024 | 548,336.00 |
| Dec 31, 2023 | 284,849.00 |
| Dec 31, 2023 | 284,849.00 |
| Sep 30, 2023 | 10.92 Mn |
| Sep 30, 2023 | 10.92 Mn |
| Jun 30, 2023 | 361,097.00 |
| Jun 30, 2023 | 361,097.00 |
| Mar 31, 2023 | 8.07 Mn |
| Mar 31, 2023 | 8.07 Mn |
| Dec 31, 2022 | 8.07 Mn |
| Dec 31, 2022 | 8.07 Mn |